The higher relevance of the GalR2, GalR3 and GalR1 gene polymorphisms in stress-induced depression and the galanin system-independent effects of the currently used antidepressants suggest that novel antidepressants acting on GalR1-3 could be developed. This evidence concerns the gene GALR1 and depressive symptom measurement.